RxDoctor Payments Data

Jody McAleer, DPM

Foot Surgery · Jefferson City, MONPI 1801868294

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (56.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Treace Medical Concepts, Inc. accounts for 99.9% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $911,232, more than ten times the $82,229 reported in 2019. Among foot surgery clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,552,030in general payments, 2019–2025

Across 1,404 payments — averaging $2529.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$3.5M
  • Stryker$2K
  • Novastep Inc.$783
  • Organogenesis Inc.$184
  • AbbVie$36
  • Elite Orthopedics, LLC$33
  • plus $25 from 2 others
$489,911in research payments, 2019–2025

Across 182 payments — averaging $2691.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Treace Medical Concepts, Inc.$490K

What the payments were for

  • Royalty or licence$1,996,84856%
  • Consulting fees$1,380,86739%
  • Travel & lodging$139,0494%
  • Food & beverage$35,2651%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,552,030 in reported general payments places this provider in the 95th percentile of 21 foot surgery providers in Missouri.

See all foot surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$103,112
Medicare patients
247
Services billed
1,049

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin24$474
Ondansetron OdtOndansetron46$448
Gabapentin35$405
Ibuprofen53$349
Terbinafine Hcl25$319
Acetaminophen-CodeineAcetaminophen With Codeine35$279
Meloxicam15$59
Tramadol Hcl14$33
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$22

Paid to pharmacies, not to this prescriber.

Other foot surgery in Jefferson City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →